Amélie Marsot

Dr. Amélie Marsot

1. Laboratoire de Suivi Thérapeutique Pharmacologique et Pharmacocinétique, Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Clinical Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
AMAmélie Marsot
Amélie Marsot
ABAudrey Boulamery
Audrey Boulamery
BBBernard Bruguerolle
Bernard Bruguerolle
Nicolas SimonNicolas Simon
Nicolas Simon

16 December 2015 in International Journal of Toxicology
Verified
Journal Article
Closed access
AMAmélie Marsot
Amélie Marsot
NSN. Simon
N. Simon
Background: Since their introduction in 2004, electronic cigarettes (e-cigarettes) have gained popularity worldwide. E-cigarettes are marketed as nicotine delivery devices. Commonly reported reasons for use include to quit smoking, to reduce urge to smoke, or the perceived lower risk alternative to smoking. But what are the actual amounts of nicotine delivered? Aim: This review summarizes all the published studies concerning nicotine or cotinine levels following e-cigarette use. Methods: A literature search was conducted from the PubMed database, from 1985 to January 2014, using the following terms: electronic cigarette(s), e-cigarette(s), electronic nicotine delivery system, cotinine, and nicotine. Articles were excluded if they were not pertinent according to our criteria. References of all relevant articles were also evaluated. Results: Eight studies were included in this review. The following information was extracted from the articles: population size, age of participants, recruitment, inclusion and exclusion criteria, concentration of nicotine in refills liquids, study sample design, and observed concentrations. Following design of studies, plasma nicotine Cmax was observed between 0 and 5 ng/mL (no significant changes) or between 13.9 and 16.3 ng/mL (similar to a tobacco cigarette) with a Tmax between 70 and 75 minutes. Cotinine levels after “vaping” an e-cigarette are similar to a tobacco cigarette. Conclusion: This review summarizes e-cigarette studies that contain information on nicotine or cotinine levels. The peak concentration of nicotine appears to be dependent on the use and dose level of e-cigarette cartridge. The value of this peak concentration is similar to the value found with a tobacco cigarette. However, the time corresponding to the peak concentration is delayed compared to a tobacco cigarette.

4 February 2020 in Clinical Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
AAAbdullah Aljutayli
Abdullah Aljutayli
AMAmélie Marsot
Amélie Marsot
FNFahima Nekka
Fahima Nekka

21 June 2016 in Clinical Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
AMAmélie Marsot
Amélie Marsot
RGRomain Guilhaumou
Romain Guilhaumou
CRCamille Riff
Camille Riff
OBOlivier Blin
Olivier Blin

16 October 2012 in Clinical Pharmacokinetics
Verified
Journal Article
Closed access
PDF file
AMAmélie Marsot
Amélie Marsot
ABAudrey Boulamery
Audrey Boulamery
BBBernard Bruguerolle
Bernard Bruguerolle
Nicolas SimonNicolas Simon
Nicolas Simon

22 August 2013 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
AMAmélie Marsot
Amélie Marsot
BIBruce Imbert
Bruce Imbert
JAJean Claude Alvarez
Jean Claude Alvarez
SGStanislas Grassin-Delyle
Stanislas Grassin-Delyle
IJIsabelle Jaquet
Isabelle Jaquet
Nicolas SimonNicolas Simon
Nicolas Simon